Sulfisoxazole

磺胺异恶唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfisoxazole
Drug Alias NameSulfafurazole磺胺异口恶唑磺胺异噁唑SulphafurazoleSulfafurazolum +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFolate inhibitors
TargetsFolate
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityObesity
Global Approved IndicationsAttention Deficit Disorder with HyperactivityObesity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1948/07/29
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityObesity

Other Information

ATC CodeJ01EB05S01AB02
Related LinksWikipediaDrugBankKEGG